Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Jan;10(1):163-170.
doi: 10.1111/jdi.12863. Epub 2018 Jun 30.

Effects of probiotic supplements on insulin resistance in gestational diabetes mellitus: A double-blind randomized controlled trial

Affiliations
Randomized Controlled Trial

Effects of probiotic supplements on insulin resistance in gestational diabetes mellitus: A double-blind randomized controlled trial

Athasit Kijmanawat et al. J Diabetes Investig. 2019 Jan.

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] J Diabetes Investig. 2019 Sep;10(5):1388. doi: 10.1111/jdi.13109. J Diabetes Investig. 2019. PMID: 31475480 Free PMC article. No abstract available.

Abstract

Aims/introduction: To evaluate the effect of probiotic supplements on insulin resistance in pregnant women with diet-controlled gestational diabetes mellitus.

Materials and methods: A randomized, double-blind, placebo-controlled trial was carried out between June 2016 and February 2017. Pregnant women with diet-controlled gestational diabetes mellitus were enrolled in the study at 24-28 weeks-of-gestation and randomized to receive either probiotic supplements containing Bifidobacterium and Lactobacillus or a placebo daily for four consecutive weeks. Primary outcomes were mean differences in insulin resistance (homeostatic model assessment for insulin resistance), fasting insulin and fasting plasma glucose between the two groups. Secondary outcomes were changes in maternal weight after the intervention.

Results: Data from 28 patients in the probiotic group and 29 in the placebo group were analyzed. The changes in metabolic parameters after randomization showed significant improvement in glucose metabolism in the probiotic group compared with the placebo group, including fasting plasma glucose (0.68 ± 5.88 vs 4.620 ± 7.78 mg/dL, mean difference -3.94 mg/dL, 95% confidence interval -7.62, -0.27, P = 0.034), fasting plasma insulin (1.11 ± 1.71 vs 3.77 ± 1.70 mIU/L, mean difference -2.67 mIU/L, 95% confidence interval -3.57, -1.76, P = 0.001) and homeostatic model assessment for insulin resistance (0.25 ± 0.37 vs 0.89 ± 0.46, mean difference -0.63, 95% confidence interval -0.86, -0.41, P = 0.001). Weight gain during randomization was similar between the two groups.

Conclusions: Four weeks of probiotic supplements in women with diet-controlled gestational diabetes in the late second and early third trimester lowered fasting glucose and increased insulin sensitivity. Probiotic supplements may be considered as an adjunct treatment for glycemic control in these patients.

Keywords: Gestational diabetes mellitus; Insulin resistance; Probiotics.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CONSORT 2010 flow diagram for ‘Effects of probiotic supplements on insulin resistance in gestational diabetes mellitus: A double‐blind randomized controlled trial.’

References

    1. Sacks DA, Hadden DR, Maresh M, et al Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel‐recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 2012; 35: 526–528. - PMC - PubMed
    1. Yogev Y, Xenakis EM, Langer O. The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control. Am J Obstet Gynecol 2004; 191: 1655–1660. - PubMed
    1. Ehrenberg HM, Durnwald CP, Catalano P, et al The influence of obesity and diabetes on the risk of cesarean delivery. Am J Obstet Gynecol 2004; 191: 969–974. - PubMed
    1. Metzger BE, Lowe LP, Dyer AR, et al Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 2008; 358: 1991–2002. - PubMed
    1. Crowther CA, Hiller JE, Moss JR, et al Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005; 352: 2477–2486. - PubMed

Publication types

Grants and funding